Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upjohn

This article was originally published in The Tan Sheet

Executive Summary

Plans to introduce an unspecified Motrin line extension in 1993 and another in 1994 under an agreement with McNeil covering OTC ibuprofen development projects, Upjohn VP and General Manager Thomas Laughlin noted. Upjohn expects to debut TV commercials featuring its newest line extension, Motrin IB Sinus, in January and will kick-off the first of a series of free-standing inserts highlighting the product on Nov. 1 ("The Tan Sheet" Sept. 20, p. 3). In addition, Upjohn is "in dialogue" with several pharmaceutical companies regarding marketing agreements for potential switch products, Laughlin said.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081989

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel